The Patent Finder

Terms ending in 2031

3-D Matrix, Ltd.

Every in-force patent on 3-D Matrix, Ltd.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,337,012Method and Composition for the Treatment, Prevention, and Diagnosis of Cancer Containing or Derived from Cancer Stem Cells
In force
 · High confidence
National Cancer CenterIn forceHigh confidence
US 10,576,123Tissue Occluding Agent Comprising an Ieikieikieiki Peptide
In force
 · High confidence
3-D Matrix, Ltd.In forceHigh confidence
US 9,133,484Transfection Agent
In force
 · High confidence
3-D Matrix, Ltd. and Nippon Medical School FoundationIn forceHigh confidence
US 10,596,225Tissue Occluding Agent Comprising An IEIKIEIKIEIKI Peptide
In force
 · High confidence
3-D Matrix, Ltd.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by 3-D Matrix, Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited